BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17352456)

  • 1. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
    Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
    Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin.
    Kim GB; Wang Z; Liu YY; Stavrou S; Mathias A; Goodwin KJ; Thomas JM; Neville DM
    Protein Eng Des Sel; 2007 Sep; 20(9):425-32. PubMed ID: 17693455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
    Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
    Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
    Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
    Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
    Matar AJ; Pathiraja V; Wang Z; Duran-Struuck R; Gusha A; Crepeau R; Tasaki M; Sachs DH; Huang CA
    Transpl Immunol; 2012 Aug; 27(1):52-4. PubMed ID: 22676970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities.
    Wang Z; Mathias A; Stavrou S; Neville DM
    Protein Eng Des Sel; 2005 Jul; 18(7):337-43. PubMed ID: 15976011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
    Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
    Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials.
    Woo JH; Lee YJ; Neville DM; Frankel AE
    Methods Mol Biol; 2010; 651():157-75. PubMed ID: 20686966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
    Wang Z; Duran-Struuck R; Crepeau R; Matar A; Hanekamp I; Srinivasan S; Neville DM; Sachs DH; Huang CA
    Bioconjug Chem; 2011 Oct; 22(10):2014-20. PubMed ID: 21866954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line.
    Liu YY; Gordienko I; Mathias A; Ma S; Thompson J; Woo JH; Neville DM
    Protein Expr Purif; 2000 Jul; 19(2):304-11. PubMed ID: 10873546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous protein.
    Hexham JM; King V; Dudas D; Graff P; Mahnke M; Wang YK; Goetschy JF; Plattner D; Zurini M; Bitsch F; Lake P; Digan ME
    Biotechnol Appl Biochem; 2001 Dec; 34(3):183-7. PubMed ID: 11730486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted introduction of a diphtheria toxin resistant mutation into the chromosomal EF-2 locus of Pichia pastoris and expression of immunotoxin in the EF-2 mutants.
    Liu YY; Woo JH; Neville DM
    Protein Expr Purif; 2003 Aug; 30(2):262-74. PubMed ID: 12880776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
    Thompson J; Hu H; Scharff J; Neville DM
    J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimization of aggregation of secreted bivalent anti-human T cell immunotoxin in Pichia pastoris bioreactor culture by optimizing culture conditions for protein secretion.
    Woo JH; Liu YY; Neville DM
    J Biotechnol; 2006 Jan; 121(1):75-85. PubMed ID: 16107287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris.
    Woo JH; Liu YY; Mathias A; Stavrou S; Wang Z; Thompson J; Neville DM
    Protein Expr Purif; 2002 Jul; 25(2):270-82. PubMed ID: 12135560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of an anti-CD3 immunotoxin increases expression and secretion of molecular chaperone BiP/Kar2p by Pichia pastoris.
    Liu YY; Woo JH; Neville DM
    Appl Environ Microbiol; 2005 Sep; 71(9):5332-40. PubMed ID: 16151122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.
    Woo JH; Liu JS; Kang SH; Singh R; Park SK; Su Y; Ortiz J; Neville DM; Willingham MC; Frankel AE
    Protein Expr Purif; 2008 Mar; 58(1):1-11. PubMed ID: 18160309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.